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Abstract
Background: Seasonal RSV infections occur every year and affect particularly children under six
months of age. Passive immunoprophylaxis with monoclonal antibody Palivizumab is recommended
in the period with high risk of RSV infection. This study aims to define the period for the southern
part of Germany (Stuttgart area).
Methods: Epidemiological analysis of the RSV situation in southern Germany from 1996 to 2004
and comparison of results with literature was made. The respiratory tract specimens were sent in
for the detection of RSV mainly by paediatric clinics. Detection of RSV was carried out mainly by
real-time RT-PCR or by ELISA "Pathfinder". RSV outbreaks were depicted as an absolute number
and as a percentage of RSV diagnoses in a month. Onsets, offsets, peaks, duration and severity of
RSV seasons were defined and analysed.
Results: An early season with strong RSV activity (early-high phase) was followed by a weaker late
season (late-low phase) in a regular biennial rhythm. However, onsets, offsets and durations of
outbreaks varied significantly from year to year. RSV epidemics in southern Germany were found
to oscillate in an antiphase with RSV epidemics in Finland and Sweden.
Conclusion: The long-term regular biennial rhythm allows predicting whether the next outbreak
will be late or early and whether RSV activity will be strong or weak. Not foreseeable, however, is
the precise time of increase and decrease of RSV activity. Moreover, the regular seasonal pattern
may be disrupted by irregular outbreaks. Thus, activity of RSV has to be monitored every year to
define the period with high risk of infection.
Background
Respiratory syncytial virus (RSV) is the most common
cause of viral bronchiolitis and pneumonia in infants and
children under two years of age. Premature infants, chil-
dren with chronic lung diseases (e.g. bronchopulmonary
dysplasia), children with congenital heart disease and
immunodeficiency patients have high risk of a severe
disease.
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There are no efficient active vaccines and causal therapy,
therefore prophylactic measures are especially important.
Prospective surveillance of RSV infection and consequent
implication of hygienic measures for preventing transmis-
sion and spread of RSV contribute effectively to reduction
of hospital-acquired infections. Moreover, a humanized
monoclonal antibody palivizumab (Synagis®, Abbott)
was licensed in September 1999 in the European Union
for passive immunoprophylaxis of RSV.
In view of the relatively low risk of RSV rehospitalisation
among premature infants and high costs of immuno-
prophylaxis, additional individual risk factors and espe-
cially the local epidemiologic situation have to be
considered in the case of Synagis®-administration [1-3].
RSV epidemics occur seasonally and last from four to six
months. North of the equator the peak incidence of dis-
ease is observed from December to April [4-6]. In Europe,
regular biennial patterns of RSV epidemics were described
in which a weaker late season was followed by a more
severe early season [7-11]. The discovery of a regular pat-
tern of RSV epidemics seemed to allow the prediction of
outbreaks.
We characterized RSV epidemics in southern Germany
with a focus on the Stuttgart area – onset, offset, peak,
intensity, duration of outbreaks and seasonal rhythm –
and compared them with already published data. The aim
of this work was to use obtained data to fix a time limit for
Synagis® prophylaxis by precisely determining the period
with high risk of RSV.
Methods
Samples
Nasopharyngeal samples were sent from paediatric hospi-
tals and practitioners from children with suspected RSV
infection. Samples were sent cooled in transport medium
Veal Infusion Broth (BD Difco™, USA).
Detection of RSV
From January 1996 to April 2001 the detection of RSV was
carried out by RT-PCR and ELISA Pathfinder (Bio-Rad,
USA). 70% of samples were tested by both methods, 20%
of samples were tested only by ELISA and 10% only by RT-
PCR. Since May 2001 only RT-PCR has been used for RSV
testing because of its higher sensitivity and specificity.
Extraction of Nucleic Acid (NA)
From January 1996 up to September 2001 NA extraction
was performed manually using the High Pure Viral
Nucleic Acid Kit (Roche Diagnostics GmbH, Mannheim,
Germany). Briefly: Virus lysis is performed by incubation
of the samples in a lysis/binding buffer in the presence of
proteinase K and poly (A) carrier RNA. NA are bound to
glass fibers and were subsequently recovered in 50 µl elu-
tion buffer by centrifugation through a glass fleece.
From September 2001 on NA extraction was performed
on the MagNA Pure LC automated instrument (Roche
Diagnostics GmbH, Mannheim, Germany) using the
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche
Diagnostics GmbH, Mannheim, Germany) for all prepa-
rations. The setting and preparation of the instrument
were performed according to the manufacturer's instruc-
tions. Briefly, 200 µl of each sample was transferred to the
sample cartridge and loaded onto the workstation
together with the kit reagents. The instrument automati-
cally performs all isolation and purification steps such as
addition of lysis/binding buffer and magnetic glass parti-
cles (MGPs), binding of DNA to the MGPs, washing steps,
elution of the pure NA (60 µl), and transfer of the NA to a
cooled storage cartridge. NA extracted in this way is ready
for use in RT-PCR applications.
RT-PCR
A Dig-ELISA RT-PCR protocol was used from September
1996 up to October 1999 together with a commercial
PCR-ELISA kit (Roche Diagnostics GmbH, Mannheim,
Germany) for amplicon detection. A real-time RT-PCR
protocol replaced the Dig-ELISA RT-PCR from October
1999 on.
For real-time RT-PCR, the LightCycler (LC) instrument
(Roche Diagnostics GmbH, Mannheim, Germany) and
primers and probes from the viral N gene, previously
described by [12] were used. To enable rapid non-type
specific simultaneous detection of both RSV subtypes,
primer pairs A21/A102 for subtype A and B17/B120 for
subtype B were used in combination with the probes
APB48 for subtype A and BPB45 for subtype B in one reac-
tion mixture. Probes contained the 5' reporter dye 6FAM
and the 3' quencher dye TAMRA (TIB MOLBIOL, Berlin,
Germany).
LC RT-PCR was performed in LC capillaries in a final reac-
tion volume of 20 µl. Master mixes were based on the
commercial QuantiTect™ Probe RT-PCR kit (QIAGEN,
Hilden, Germany) supplemented with primers A21/
A102/B17/B120 (f.c. 1,0 µM each), the probes APB48 and
BPB45 (f.c. 0,25 µM each) and heat labile UNG (0,2 U)
(Roche Diagnostics GmbH, Mannheim, Germany). Use of
this kit allows both reverse transcription and PCR to take
place in a single capillary, so there is no need to open the
capillary once reverse transcription is accomplished. After
pipetting of 13,2 µl of this reaction mixture into LC capil-
laries, 6,8 µl of the crude NA preparation was added. A 5
min. step at room temperature to enable UNG activity is
followed by 20 min. of reverse transcription at 50°C. PCR
is started with a 15 min. step at 95°C followed by 10BMC Infectious Diseases 2005, 5:20 http://www.biomedcentral.com/1471-2334/5/20
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cycles of denaturation (95°C for 5 sec), annealing (with a
1°C decrease per cycle from 65°C to 55°C for 20 sec) and
extension (72°C for 15 sec), followed by 40 cycles of
denaturation (95°C for 0 sec), annealing (55°C for 20
sec) and extension (72°C for 30 sec).
Epidemiological analysis
Epidemiological analysis included nine RSV seasons from
January 1996 to June 2004. Only samples sent by hospi-
tals and practitioners in southern Germany (Baden-Würt-
temberg and Bavaria) were analyzed in this study. 80% of
samples were sent from hospitals in the Stuttgart area. The
following data were extracted from the laboratory data-
base: laboratory identification number, age, sample with-
drawal date, sender address and RSV antigen detection test
results.
Onset, offset, peak and duration of outbreaks were deter-
mined for each year. In order to distinguish between the
beginning/ending of an outbreak and background activ-
ity, the number of sporadic RSV cases in the summer
months from June to October were calculated. A maxi-
mum of 5 cases in a month and 2 cases in a week were reg-
istered in this time. Therefore, onset month (week) of
outbreak was defined as the first of two consecutive
months (weeks) with at least 5(2) positive RSV findings.
Offset month was defined as the last of the final two con-
secutive months (weeks) with at least 5(2) positive RSV
findings. Duration was defined as the number of months
(weeks) between the calculated onset and offset months
(weeks) inclusive of those months (weeks). Outbreak
peak was defined as the month (week) after onset with the
highest number of positive test results.
Outbreaks were graphically depicted in two different
forms: an epidemic curve by plotting the number of cases
on the vertical axis and time on the horizontal axis and a
graphic showing percentage of positive test results in a
month.
The total number of positive RSV findings was considered
for estimation of outbreak intensity.
Results
Nasopharyngeal samples from a total of 3577 patients
were tested in the period from January 1996 to June 2004.
32% of samples (1154) were found to be positive.
Our customers, paediatric hospitals and practitioners,
who sent the samples, remained the same over the time
period. 80% of samples were sent in by children's hospi-
tals, 10% by practitioners and 10% by other private med-
ical-diagnostic laboratories.
The age distribution of patients tested positive reflected
the distribution for the whole material sent in: approxi-
mately 40% of RSV were infants younger than 3 months,
30% of those aged 3 to 6 months, 20% 7–12 months and
10 % 1 to 3 years. Patients older then 3 years were rarely
tested (less then 1%).
From Januar 1996 to April 2001 a total of 1653 samples
were tested both by EIA and RT-PCR. The sensitivity of EIA
versus RT-PCR was 41% (112/273), specificity 98%
(1358/1380).
The epidemic curve (Fig. 1) shows the seasonal distribu-
tion of acquired positive RSV results by month. The high-
est RSV activity was registered in the period from late
autumn to spring. A clear biennial cycle of successive RSV
outbreaks can be seen: Late weak seasons 1995/96, 1997/
98, 1999/00, and 2001/02 (late-low phase, minor peaks)
followed by more severe early seasons 1996/97, 1998/99,
2000/01 and 2002/03 (early-high phase, major peaks).
Table 1 shows that the onsets, offsets and durations of
outbreaks varied significantly from season to season. The
late season can start relatively early in week 50 or relative
late in week 6.
Fig. 2 presents the seasonality of RSV detection as a per-
centage of samples tested positive per month. Year-to-year
alternation between late and early seasons can also be
seen in Fig. 2 as in a Fig. 1. The monthly percentage of pos-
itive results in early-high seasons was the same as in late-
low seasons or actually lower. Therefore any difference of
the epidemics intensity cannot be established.
The comparison of seasonal rhythms with literature and
surveillance data showed that RSV outbreaks in Stuttgart
followed the same pattern as in Freiburg and in Switzer-
land. In Kiel the seasons from 1994/95 to 1996/97 started
late. Since 1997/1998 the same 2-year cycle could be
detected in Kiel as in Stuttgart and Freiburg. RSV epidem-
ics in Finland and Sweden occurred synchronously with
regular rhythm (high-early versus low-late phase), but
were in antiphase with Germany RSV outbreaks (Table 2).
Discussion
Age distribution analysis of our patients with diagnosed
RSV infection confirmed once more that very small
infants younger than three months have the highest risk of
hospitalisation and therefore of being tested for RSV [9].
Sensitivity of EIA calculated versus RT-PCR was found to
be very low, only 41 %. In the few studies in which Path-
finder RSV EIA was evaluated the sensitivity (up to100%)
of this assay was calculated only in comparison with other
less sensitive methods than PCR, such as cell culture, shell
vial assay or direct immunofluorescence [13]. The lowBMC Infectious Diseases 2005, 5:20 http://www.biomedcentral.com/1471-2334/5/20
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sensitivity of EIA in our study can also be explained with
the instability of RSV, even though appropriate collection
and transport conditions were assured. In addition, it
must be considered that the nasal quantity of RSV corre-
lates with disease severity in hospitalised infants [14]. In
our study, the use of EIA did not affect the proportion of
positives, since only a small number of samples were
tested by this method only.
The discovered in Stuttgart long-term regular biennial
rhythm allows prediction of whether the next outbreak
will be late or early and whether RSV activity will be strong
Absolute number of total RSV investigations and positive results by month, from January 1996 to May 2004 Figure 1
Absolute number of total RSV investigations and positive results by month, from January 1996 to May 2004.
Table 1: Onset, peak, offset and duration (weeks) of RSV Outbreaks in Stuttgart, from 1996 to 2004.
Season Onset Peak Offset Duration
1995/1996 late season 1 12 17 17
1996/1997 early season 49 8 13 16
1997/1998 late season 2 13 20 19
1998/1999 early season 48 5 18 24
1999/2000 late season 50 14 19 23
2000/2001 early season 48 6 15 21
2001/2002 late season 6 20 23 18
2002/2003 early season 45 51 6 14
2003/2004 late season 1 14 19 19
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or weak. However, the value of this prediction is limited.
The precise time of increase and decrease of RSV activity is
not foreseeable (Table 1). Only local monitoring of RSV
activity allows definition of the period with high risk of
infection. Therefore, since November 2003 Laboratory
Enders & Partner has published weekly from late autumn
to spring the actual RSV epidemiological situation in the
Stuttgart area on its website [15]. It is noted that our mon-
itoring focused mainly on hospitalised children. With
regard to RSV, this approach is acceptable while the pro-
portion of RSV infections among inpatients is higher than
in outpatients. However, a population-based approach
used in the PRI.DE study may be more sensitive in the
detection of offsets because it includes outpatients [16].
There is no generally accepted method for surveillance of
RSV outbreaks. In order to compare the RSV epidemiolog-
ical situation in Stuttgart with that in other areas, we
investigated primarily which methods of RSV outbreak
analysis are usually used.
In Europe, Waris [7] described nine RSV seasons. He ascer-
tained the number of RSV laboratory diagnosis made at
the Department of Virology, University of Turku, Finland
per month in the time period from January 1981 to March
1990, and discovered a regular periodic biennial pattern
of occurrence of RSV outbreaks. A weaker late season was
followed by a more severe early season. Other similar epi-
demic curves were depicted by Reyes (seasons 1984–
1993, Karolinska Institute, Sweden) [8], Berner (seasons
1988–1999, University of Freiburg, south Germany) [9],
Weigl (seasons 1994–2001 University of Kiel, north Ger-
many 2002) [10] and Duppenthaler (seasons 1988–2001,
Switzerland) [11].
In the USA, the national Respiratory and Enteric Virus Sur-
veillance System (NREVSS) monitors and summarizes the
RSV surveillance results starting in July 1985 and pub-
lishes them on the NREVSS website [17]. The RSV activity
in NREVSS reports is shown as median percent of positive
for RSV results per month (week) and region. Onsets/off-
sets are defined as the first/last of two consecutive weeks
Percentage of RSV positive cases by month, from January 1996 to May 2004 Figure 2
Percentage of RSV positive cases by month, from January 1996 to May 2004.
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(months) of at least 10% positive test results with at least
two positive samples in the numerator of the reports of
both weeks (months) [4,5].
In our study both methods of outbreak analysis were
used. We acquired the number and percentage of positive
cases per month.
Monitoring of RSV activity by calculation of the percent-
age of positive RSV detection in comparison to the
number of positive cases has the advantage that the results
show the real RSV situation independently of changes in
population. Also, in our study, in outbreaks months at
least 10% of samples were positive. However, in summer
weeks, in which only few samples were sent in, the posi-
tive rate could be over 10% by only one positive sample.
Therefore, it is also important to consider the number of
sporadic cases in order to distinguish between the begin-
ning/ending of an outbreak and background activity.
Onset, offset and peak months on the plot with the per-
centage curve were nearly the same as on the plot present-
ing the absolute number of positive cases. Early and late
seasons were recognisable on our plot with the percentage
curve. These fluctuations of RSV season onset weeks can
also be observed in two Omaha Nebraska NREVSS surveil-
lance laboratories [5]. It is noted that on the plot with per-
centage curve the intensity of epidemics cannot be seen. In
seasons with low RSV intensity (small number of sam-
ples) the positive rate was as high (50–60%) as in seasons
with high RSV activity. Therefore, this information is miss-
ing in NRVSS reports. Only the combination of both
approaches to the monitoring of RSV outbreaks supplies
complete information for the estimation of the epidemio-
logical situation.
European surveillance centres present RSV data in differ-
ent ways: The Pediatric Infectious Diseases Network on
Acute Respiratory Tract Infections (PID-ARI.Net)
Web&Warnsystem [18] (Kiel, Freiburg and Mainz, Ger-
many) shows tables and incidence plot, the North Saxon
State Health Office (NLGA) (Hanover, Germany) [19]
uses percentage plot, the Swedish Institute for Infectious
Disease Control (SMI) [20] presents tables, the Infectious
Diseases Information System (ISIS) (the Netherlands)
[21] shows different plots and tables. The use of different
methods complicates the interpretation of data. As far as
possible we compared seasonal RSV rhythm in Stuttgart
with other European reports (Table 2).
This comparison showed that RSV seasonality in Stuttgart
was in accordance with other areas of Germany and Swit-
zerland [9-11,16,18]. The explanation for the absence of a
regular pattern in Kiel before 1996 may be the low total
number of samples tested and, therefore, the possibility of
missed cases. The other possible explanation may be
found by analyzing RSV epidemics in northern Europe.
RSV epidemics in Finland and Sweden were also synchro-
Table 2: Comparison of seasonal rhythm in European areas.
RSV Seasons Finland [7] Sweden [8] Switzerland [11] Germany, Freiburg [9] Germany, Kiel [10,18] Germany, Stuttgart
1982/1983 late
1983/1984 early
1984/1985 late late
1985/1986 early early
1986/1987 late late
1987/1988 early early
1988/1989 late late early
1989/1990 early early late
1990/1991 late early early
1991/1992 early late late
1992/1993 late early early
1993/1994 early late late
1994/1995 early early late
1995/1996 late late late
1996/1997 early early late early
1997/1998 late late late
1998/1999 early early early
1999/2000 late late late
2000/2001 early early
2001/2002 late late
2002/2003 early early
2003/2004 late lateBMC Infectious Diseases 2005, 5:20 http://www.biomedcentral.com/1471-2334/5/20
Page 7 of 7
(page number not for citation purposes)
nized in time as outbreaks in Germany, but the early-high
phase in northern Europe corresponded with late-low
phase in southern Germany. Kiel is possibly located at the
borderline between two areas with different rhythms [22].
Even in areas with a regular rhythm it may shift. Such a
switchover can be observed in Chile. The figure depicted
by Avendano, which presents RSV detection from 1989 to
2000, shows that after two cycles of late/early seasons the
following season 1994 began repeatedly early, then the
rhythm was resumed [23]. Also, in Gambia a regular pat-
tern of outbreaks during 6 consecutive annual seasons was
disrupted by 2 years of irregular outbreaks, followed by
another 2 years of regular seasonal outbreaks [24].
Conclusion
The long-term regular biennial rhythm allows predicting
whether the next outbreak will be late or early and
whether RSV activity will be strong or weak. Not foreseea-
ble, however, is the precise time of increase and decrease
of RSV activity. Thus, activity of RSV has to be monitored
every year to define the period with high risk of infection.
Moreover, different rhythms of epidemics in Europe and
the theoretical possibility of their shift demonstrate that
the present regionally limited monitoring is not sufficient.
An RSV surveillance system in Europe similar to the exist-
ing influenza surveillance system is required. Analysis of
spatio-temporal European data will contribute to the
understanding of RSV epidemiology and predicting out-
breaks. Correct identification of outbreaks will permit the
limiting of the time period for Synagis® administration
and thus save costs.
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